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Abstract
Background: The effects and effectiveness of the chaperone pair GroELS on the yield and quality of recombinant
polypeptides produced in Escherichia coli are matter of controversy, as the reported activities of this complex are
not always consistent and eventually indicate undesired side effects. The divergence in the reported data could be
due, at least partially, to different experimental conditions in independent research approaches.
Results: We have then selected two structurally different model proteins (namely GFP and E. coli b-galactosidase)
and two derived aggregation-prone fusions to explore, in a systematic way, the eventual effects of GroELS co-
production on yield, solubility and conformational quality. Host cells were cultured at two alternative temperatures
below the threshold at which thermal stress is expected to be triggered, to minimize the involvement of
independent stress factors.
Conclusions: From the analysis of protein yield, solubility and biological activity of the four model proteins
produced alone or along the chaperones, we conclude that GroELS impacts on yield and quality of aggregation-
prone proteins with intrinsic determinants but not on thermally induced protein aggregation. No effective
modifications of protein solubility have been observed, but significant stabilization of small (encapsulable)
substrates and moderate chaperone-induced degradation of larger (excluded) polypeptides. These findings indicate
that the activities of this chaperone pair in the context of actively producing recombinant bacteria discriminate
between intrinsic and thermally-induced protein aggregation, and that the side effects of GroELS overproduction
might be determined by substrate size.
Introduction
Recombinant protein production is a leading methodo-
logical platform of biotechnology and biomedicine [1].
Protein misfolding, degradation, aggregation, inclusion
body formation and low functional protein quality are
among the main obstacles encountered when using con-
ventional bacterial hosts such as Escherichia coli [2-4] as
cell factories, these events being specially distressing
when proteins are intended for therapeutic uses [5,6].
Apart from shifting to a growing number of alternative
hosts, what might eventually improve protein yield and
quality, several strategies have been implemented to
favour recombinant protein yield and quality in bacteria,
specially addressed to enhance proteolytic stability and
minimize aggregation [3,7]. As the activities of the cell’s
quality control were identified ([8], and references
therein), the co-production of chaperones along with
the target protein was taken as a routine approach.
Firstly individual chaperones, and later chaperone-co-
chaperone pairs or larger chaperone sets, supplied from
additional plasmid vectors, have been assayed as folding
modulators under different experimental setting ups and
for a large catalogue of proteins [9]. Despite reports of
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relevant successes, a consensus about final doses and
composition of the best chaperone catalogue has not
been reached, as the positive effects of this strategy
seem to be highly dependent, among other potential fac-
tors, on the specific recombinant protein. In addition,
externally supplied chaperones might show side effects
on the whole physiology of recombinant cells and even-
tually compromise the quality, solubility or yield of the
target recombinant protein [10,11]. Such undesired
effects might limit the success of this method, and their
occurrence can account, at least partially, for the lack of
consistency of chaperone co-production as a generic
strategy.
DnaK, a key negative regulator of the quality control
system and the main cytosolic E. coli chaperone (acting
together with its co-chaperone DnaJ) is a common com-
ponent of the most successful chaperone sets [9,12].
However, an excess of DnaK is recognized to promote
functional inactivation of the target protein and even-
tually its massive proteolysis, at least in given experi-
mental setting ups [13-15]. Protein degradation
mediated by DnaK seems to be mechanistically con-
nected to the disaggregation process on the surface of
inclusion bodies (where DnaK accumulates), in which by
DnaK-DnaJ, IbpA-IbpB and ClpP participate [16].
DnaK-mediated degradation of recombinant polypep-
tides might represent a physiological replica of s32 inac-
tivation, through its DnaK-mediated delivery to the
protease La during the regulation of the heat shock cir-
cuits [17]. Recombinant protein production in DnaK
knock out mutants, in contrast, results in high yields of
recombinant protein and larger inclusion bodies [18].
The activities of GroEL, the other main cytosolic cha-
perone in E. coli, on recombinant protein solubility, but
specially their potential side effects on protein quality
are much less known. This might be due to the fact that
GroEL knock out mutants are not viable [19], and that
studies on partially inactivating groEL mutations [20] or
truncated versions of the chaperone [21] might render
non conclusive results. GroEL co-production has been
shown to enhance solubility and/or yield of different
proteins, at very different extents (although sometimes
with no perceivable or very mild effects) and under dif-
ferent production conditions [22]. GroELS, apart from
acting in the sequential folding steps of nascent poly-
peptides [23-26], is a holding chaperone that can also
promote natural and recombinant protein stability and
the formation of large macromolecular complexes such
as tobacco mosaic virus-like particles [27] and fully
assembled P22 phage virions [28], by preventing aggre-
gation and proteolysis of thermolabile intermediates.
However, the effects of these chaperones on recombi-
nant protein yield and functional quality are extremely
difficult to summarize since diverse authors focus on
different analytical parameters, with alternative criteria
and under diverse experimental conditions. Also, the
potential contribution of thermally induced aggregation
of intrinsically aggregation-prone proteins in GroELS
activities has been essentially neglected. Beside these
findings and considerations, independent observations
have again suggested instability of target proteins as
potential, undesired effects associated to GroEL overpro-
duction [10], in special, proteolysis of proteins deposited
as inclusion bodies [29].
Results
To examine in a defined experimental setting up, how
GroEL and its co-chaperone GroES can affect the yield,
stability and quality of aggregation-prone polypeptides,
and to identify mechanistic roles of this chaperone pair
in the quality control of recombinant proteins we have
selected as models two structurally dissimilar soluble
proteins (namely GFP and E. coli b-galactosidase). These
polypeptides were produced as non-fused, pseudo wild
type versions or joined to a hydrophobic viral protein
(the VP1 capsid protein of foot-and-mouth disease
virus) that acts as an efficient aggregation tag. While
GFP is a monomeric small protein (27 kDa) that gains
activity through a maturation process in the last folding
steps [30], b-galactosidase is a huge tetrameric protein
(470 kDa) that becomes active once the correct contacts
between the monomer’s interfaces have been stabilized
[31]. Point mutations in GFP have a dramatic impact on
the aggregation rate of the protein [32] while disposition
of both GFP (and related fluorescent proteins) and b-
galactosidase as inclusion bodies is also sensitive to the
amino acid sequence and position of end-terminal fused
aggregation tags [33-35]. Aggregation-prone versions of
both proteins have been shown to interact in vivo with
GroEL [36-38].
To minimize the contribution of thermal stress on
protein deposition we tested recombinant protein pro-
duction at two suboptimal growth temperatures, namely
16°C and 27°C. The non-fused GFP was fully soluble
when produced in E. coli at 16°C (Figure 1A). However,
around 40% of recombinant GFP occurred in the insolu-
ble cell fraction when the culture temperature was up-
set to 27°C (Figure 1A). Co-production of GroELS did
not improve GFP solubility in any of these production
conditions (Figure 1A). Also, GFP yield was very similar
in all cases, excluding the possibility of extended proteo-
lysis mediated by the chaperones. In contrast, the aggre-
gation-prone version of the same protein (VP1GFP) was
mainly insoluble at both 16°C and 27°C (Figure 1B),
indicating an intrinsic rather than environmental-
induced trend to deposition mediated by the viral tag.
The yield of VP1GFP at 27°C was significantly lower
than that at 16°C, suggesting proteolysis of this protein.
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However, and in contrast with GFP, the co-production of
GroELS dramatically enhanced the yield of VP1GFP (Fig-
ure 1B). Furthermore, VP1GFP solubility, expressed as the
ratio of protein occurring in the soluble fraction over total
protein, was not dramatically enhanced by the chaperones
at 27°C (Figure 1B). The five-fold increase in solubility
observed at 16°C might be a numerical rather than a fac-
tual issue linked to data scattering at low yield values.
When exploring GFP conformational and functional
quality through the fluorescence emitted per mass ratio,
higher conformational quality was immediately evi-
denced at 27°C (Figure 2A), indicative of a more
efficient protein maturation. At this temperature, the
soluble protein version was slightly more fluorescent
than the aggregated counterparts, as expected. GroELS
had no detectable effect on the fluorescence emission of
GFP at any temperature (Figure 2A). A similar global
profile was observed during the production of VP1GFP.
However, in this case, the chaperone complex mini-
mized the fluorescence emission of both soluble and
aggregated versions of VP1GFP (Figure 2B), whose yield
was enhanced by the chaperones.
b-Galactosidase was, as in the case of GFP, essentially
soluble and both protein yield and solubility essentially
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Figure 1 Influence of GroELS co-production on yield and solubility of native and engineered GFPs. Yield of total (T) and soluble (S) GFP
(A) and VP1GFP (B) produced alone or along with the chaperones GroELS (+). Only significant differences between relevant data pairs are
indicated as *, 0.01 <p < 0.05 and ** p < 0.01.
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Figure 2 Influence of GroELS co-production on the conformational quality of native and engineered GFPs. Specific fluorescence emission
of total (T) and soluble (S) fractions of GFP (A) and VP1GFP (B) alone or along with the chaperones GroELS (+). Specific fluorescence was
calculated as the ratio of fluorescence versus recombinant protein amounts. Only significant differences between relevant data pairs are
indicated as *, 0.01 <p < 0.05 and ** p < 0.01.
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unaffected by the external supply of GroELS (Figure
3A). On the other hand, 50% of recombinant VP1LAC
was found in the insoluble cell fraction irrespective of
GroELS co-production (Figure 3B). No temperature-
induced aggregation was observed in any case. Again,
no symptoms of proteolysis were manifest regarding any
of the b-galactosidase versions (Figure 3), although a
minor, non significant reduction of b-galactosidase yield
observed at both 16°C and 27°C could be compatible
with GroELS-mediated degradation (Figure 3A). In this
line, and irrespective of the events supporting the lower
yield, the enzymatic activity of non-fused b-galactosidase
was concomitantly higher in presence of externally sup-
plied GroELS (Figure 4A). Again, this trend was not sta-
tistically significant although the inverse coincidence
between yield and specific activity of the protein was
evident. In contrast, the yield and functional quality of
the largest protein version VP1LAC were essentially reg-
ular and it was unaffected by the chaperone pair (Fig-
ures 3B and 4B).
In conclusion, co-production of GroELS along with
non-fused, full length GFP did not have any effect on
protein yield, stability and quality at 16°C (Figure 1A),
conditions under which this protein was fully soluble.
At 27°C, GFP partially aggregated, indicating thermal
aggression and conformational effects even at this mild
temperature. GroELS pair was not able to recover the
solubility of the protein under these conditions (Figure
1A), and neither its functional quality expressed as spe-
cific fluorescence emission (Figure 2B). On the other
hand, no signs of GFP or VP1GFP proteolysis associated
to GroELS production were observed (Figure 1),
although a slight reduction in the yield of b-
galactosidase was evidenced in presence of the recombi-
nant chaperones (Figure 3), that might be compatible
with the occurrence of degradation. Contrarily, GroELS
dramatically enhanced the yield of VP1GFP (Figure 2),
what could be in turn associated to a stabilizing effect
of the chaperone pair on the chimerical protein. Conco-
mitantly, GroELS reduced the fluorescence emission of
both soluble and insoluble VP1GFP versions (Figure 2B).
Discussion
The examination of the solubility and conformational
quality of non-fused and chimerical versions of two
structurally different model proteins indicate that the
GroELS chaperone pair does not modulate the folding
of thermally-injured GFP, but instead that of the aggre-
gation-prone version of this protein (VP1GFP), which
size (around 50 kDa) should still permit its encapsula-
tion by GroELS complexes [39]. This suggests a differ-
ential role of GroELS in thermal induced and intrinsic
aggregation pathways of their substrates. Although there
is not straightforward experimental data fully demon-
strating this hypothesis, data presented in Figure 1B sug-
gest a proteolytic stabilization of VP1GFP that enhances
its yield. In agreement with previous observations [15],
such an increase in the intracellular concentration of
the chimerical protein reduces its conformational qual-
ity, in both soluble and insoluble cell fractions (Figure
2). This fact indicates that recombinant protein yield
and quality are divergent features and supports the con-
cept that both parameters cannot be simultaneously
enhanced in E. coli [40], at least for aggregation-prone
proteins. Such a divergence is also supported by the
slight increase of b-galactosidase activity mediated by
VP1LAC
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Figure 3 Influence of GroELS co-production on yield and solubility of native and engineered b-galactosidases. Yield of total (T) and
soluble (S) b-galactosidases (A) and VP1LAC (B) produced alone or along with the chaperones GroELS (+). Only significant differences between
relevant data pairs are indicated as *, 0.01 <p < 0.05 and ** p < 0.01.
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GroELS concomitant to the reduction of protein yield
(Figures 3A and 4A). Also, the parallel behaviour
regarding functional activity of soluble and insoluble
GFP versions is in the line of the “continuum-of-forms”
model of recombinant protein production in bacteria
[41], that claim for the extreme dynamism of protein
aggregation-disaggregation [37] and that offers a
mechanistic explanation about why insoluble protein
species are not excluded from the cell’s quality control
[42]. GroELS was not able to positively reduce aggrega-
tion of VP1GFP (Figure 1B), a role that seems limited to
DnaK and associated AAA+ disaggregating proteins [43].
Finally, overproduction of GroELS shows extremely
mild effects on the production of two versions of the
large b-galactosidase protein, which cannot be encapsu-
lated by GroEL rings. This is in agreement with previous
observations of GroEL null effects on the folding of
RNA polymerases [44] and other large proteins [10]. In
our hands, GroEL tends to reduce the yield of b-galacto-
sidase without affecting the partitioning between soluble
and insoluble cell fractions, suggesting a negative role of
this chaperone on protein stability, as shown before for
a limited set of abnormal and native cellular proteins
[45-48]. In this regard, it has been observed that GroEL
interacts externally (without the cooperation of GroES)
with proteins too large to be encapsulated [49]. The
negative influence of GroELS on protein yield, although
no statistically significant, is supported by the rise of the
specific enzymatic activity in GroELS-producing cells.
In summary, we have not observed any positive effect
on the yield, production and folding of thermally aggre-
gated GFP but positive GroELS activities on the yield of
an aggregation-prone version of GFP (VP1GFP).
Variations in the nominal solubility of these proteins
(determined as soluble protein amounts over total pro-
tein) during overproduction of the chaperone pair seem
to be irrelevant numerical alterations of these ratios
derived from data scattering, as no solubilising effects of
GroELS were in any case evidenced through a reduction
of the absolute amounts of insoluble species. The
increase of VP1GFP yield, especially dramatic at 16°C,
can be attributed to protein stabilization. Contrarily,
GroELS co-production has mild (if any) effects on large
proteins that cannot be encapsulated, on which, how-
ever, the chaperone pair tends to reduce their proteoly-
tic stability.
Methods
Bacterial strain, plasmids and proteins
The E. coli strain (MC4100 (araD139 (argF-lac)U169
rpsL150relA1 flbB5301 deoC1 ptsF25 rbsR)) was used in
all the experiments. The recombinant proteins were pro-
duced by expressing the encoding genes from the ampi-
cillin-resistant pTrc99A-derivatives pTGFP (encoding
GFP), pTVP1GFP (encoding VP1GFP), pTCO46 (encod-
ing a pseudo-wild type b-galactosidase) and pTVP1LAC
(encoding VP1LAC). No leader peptides were fused in
any case so all the proteins remained in the cell’s cyto-
plasm. More details about these constructs where pro-
vided elsewhere [15,33,35]. GroELS pair was supplied
from the plasmid pBB541 (KmR), kindly provided by
Prof B. Bukau.
Culture and sampling conditions
LB medium [50] with the corresponding plasmid-main-
tenance antibiotics (ampicilin at 100 μg/ml and
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Figure 4 Influence of GroELS co-production on the conformational quality of native and engineered b-galactosidases. Specific activity
of total (T) and soluble (S) b-galactosidases (A) and VP1LAC (B) produced alone or along with the chaperones GroELS (+). Only significant
differences between relevant data pairs are indicated as *, 0.01 <p < 0.05 and ** p < 0.01.
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kanamycin at 60 μg/ml, when necessary) was used in all
the experiments. Cells from overnight cultures were
diluted at 1:50 in 120 ml of fresh media and grown at
either 16°C or 27°C, within 500 ml shake flasks, at 250
rpm. Induction of gene expression (encoding both the
models protein and the chaperone set) was triggered by
the addition of 1 mM IPTG at an OD550 = 0.5. Cultures
were always done in triplicate to ensure statistic
robustness.
Sampling and protein analysis
Samples of 15 ml were taken when OD550 reached 2-
3, after the induction of gene expression and cells
sedimented by low speed centrifugation at 6.000 g for
10 min. Cells were disrupted by sonication as
described [51] and soluble cell fraction recovered by
centrifugation at 15.000 g for 15 min. Total cell
extracts and the separated soluble cell fraction were
run in PAGE-electrophoresis as described [15] and
protein bands identified by further Western blot ana-
lysis, using commercial anti-GFP and anti-b-galactosi-
dase antibodies as described [35]. The amount of
proteins was determined by Quantity One® software
using dilutions of commercial GFP and b-galactosi-
dase proteins as standards. Fluorescence emission and
b-galactosidase enzymatic activity were determined by
standard fluorimetry or enzymatic determination
(Miller’s method) respectively [35]. Significance of dif-
ferences between relevant data pairs were evaluated by
a Student’s t-test.
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